Effects of Prolonging Peak Dobutamine Dose During Stress Echocardiography
- 1 March 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 29 (3) , 526-530
- https://doi.org/10.1016/s0735-1097(96)00558-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Electrocardiographic response during dobutamine stress echocardiographyAmerican Heart Journal, 1995
- Optimal stage duration in dobutamine stress echocardiographyJournal of the American College of Cardiology, 1995
- Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarctionJournal of the American College of Cardiology, 1994
- Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction.Circulation, 1993
- Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.Circulation, 1993
- Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: Combination with echocardiography or scintigraphy, or both?Journal of the American College of Cardiology, 1993
- Ischemia-induced regional wall motion abnormality is improved after coronary angioplasty: Demonstration by dobutamine stress echocardiographyJournal of the American College of Cardiology, 1993
- Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomographyJournal of the American College of Cardiology, 1990
- Dobutamine pharmacokinetics in severe heart failureClinical Pharmacology & Therapeutics, 1978
- Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.Circulation Research, 1975